Skip to content

Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy

Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06073483
Enrollment
10
Registered
2023-10-10
Start date
2023-10-15
Completion date
2024-06-15
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

This clinical study was a prospective, single-center, single-arm exploratory study. Subjects who meet the inclusion criteria will be enrolled in this study, where surgeons will perform 5G remote gastrectomy on subjects using the Toumai endoscopic surgery system, and explore and evaluate the safety and efficacy of this clinical application.

Interventions

DEVICEToumai Endoscopic surgery System

5G remote gastrectomy on subjects using the Toumai endoscopic surgery system

Sponsors

Hebei Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. 18 years old ≤ actual age ≤80 years old. 2. Patients requiring gastrointestinal endoscopic surgery. 3. Willing to cooperate with and complete the study follow-up and related examinations. 4. Voluntarily participate in the study and sign the informed consent in person.

Exclusion criteria

1. Have serious cardiovascular or circulatory disease and cannot tolerate surgery. 2. Participated in other clinical trials within the last 3 months. 3. Inability to understand trial requirements, or inability to complete the study follow-up plan. 4. Researchers believe that there are other circumstances that are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frameDescription
The rate of intraoperative complicationsThe day of surgeryIntraoperative complications, including organ injury and vascular injury, were evaluated using the Satava grading system to determine whether the occurrence of complications was related to the study instrument or surgery
The rate of postoperative complicationsPostoperative 30 daysPostoperative complications, including postoperative bleeding, fever, and incisional infection, were evaluated using the Clavien-Dindo grading system to determine whether the occurrence of complications was related to the study instrument or surgery.

Secondary

MeasureTime frame
Intraoperative blood lossThe day of surgery
Operation timeThe day of surgery
Intraoperative system failure rateThe day of surgery
Intraoperative instrument operation error rateThe day of surgery
Preoperative device assembly timeThe day of surgery
Surgical completion rateThe day of surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026